Authors
Matei Seleusan, Diana Cenariu, Diana Gulei, David Kegyes, Adrian Bogdan Tigu, Sadia Riaz, Mihnea Zdrenghea, Ciprian Tomuleasa
Published in
Critical reviews in oncology/hematology. Pages 105651. Oct 15, 2026. Epub Oct 15, 2026.
Abstract
Classical Hodgkin lymphoma (cHL) is singular because rare Hodgkin and Reed-Sternberg (HRS) cells survive within an abundant inflammatory tumor microenvironment (TME) - despite originating from germinal center (GC) B cells that would normally be negatively selected, they persist through coordinated disruption of lineage fidelity, immune recognition, and cell-death execution. The present review integrates mechanistic, translational, and therapeutic evidence on apoptosis resistance, survival signaling, microenvironmental support, immune evasion, Epstein-Barr virus-associated rescue mechanisms, and senescence-like phenotypes in cHL, with particular emphasis on how these processes converge to stabilize an aberrant HRS-cell fate by raising the apoptotic threshold. HRS cells retain several elements of apoptotic competence, including death receptors, functional mitochondrial apoptotic machinery, and frequently wild-type TP53; however, these factors are functionally restrained by multiple antagonistic mechanisms: c-FLIP inhibits pro-caspase-8 activation, constitutive NF-κB, JAK/STAT and PI3K/AKT signaling sustain survival, BCL-2-superfamily overexpression confers resistance to intrinsic apoptotic stimuli, MDM2 overactivity suppresses p53, and microenvironment-derived secretory products and contact-dependent ligands provide stabilizing support. The inflammatory niche reinforces HRS-cell persistence by converting immune proximity into immune privilege through altered antigen presentation, PD-1/PD-L1 signaling, spatially inhibitory rosetting structures, regulatory T-cell prevalence, M2-macrophage polarization, and cytokine-mediated paracrine and autocrine survival circuits. Emerging evidence indicates that Reed-Sternberg cells (RS) acquire senescence-like features and secretory programs that contribute to constructing the inflammatory niche. cHL can therefore be understood as a malignancy of failed fate execution, in which apoptosis, differentiation and immune clearance remain available but are rendered non-executable by convergent intrinsic and microenvironmental survival circuits.
PMID:
42880615
Bibliographic data and abstract were imported from PubMed on 16 Oct 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0